PAB 0.00% 0.7¢ patrys limited

Ann: Manufacturing Update - Clinical Trial Remains on Hold, page-4

  1. 27 Posts.
    Time to sell...nothing left here. Without PAT-SM6 there is no clinical value in the company...everything is far behind. So, this is now an early preclinical company with no reliable solution on how to make their only products. With cash running out, where are they going to go?????????
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.